Genentech Will Focus On Pipeline For Near-Term Growth, CEO Says
Executive Summary
Genentech's near-term growth will be based on its product pipeline rather than through acquisitions, CEO Arthur Levinson, PhD, told analysts during the company's fourth quarter earnings call Jan. 16